DNA Binding and Topoisomerase I Poisoning Activities of Novel Disaccharide Indolocarbazoles-Reference-Cited by-同舟云学术

DNA Binding and Topoisomerase I Poisoning Activities of Novel Disaccharide Indolocarbazoles

Published:2002-11-01 Issue:5 Volume:62 Page:1215-1227
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Facompre Michaël,Carrasco Carolina,Colson Pierre,Houssier Claude,Chisholm John D.,Van Vranken David L.,Bailly Christian

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. Syntheses and Biological Activities (Topoisomerase Inhibition and Antitumor and Antimicrobial Properties) of Rebeccamycin Analogues Bearing Modified Sugar Moieties and Substituted on the Imide Nitrogen with a Methyl Group

2. Novel indolocarbazole compound 6-N-formylamino-12,13-dihydro-1, 11-dihydroxy-13-(β-d-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo-[3,4-c]carbazole-5,7-(6H)-dione (NB-506): its potent antitumor activities in mice.;Arakawa;Cancer Res,1995

3. New developments in antitumor anthracyclines

4. Formaldehyde-Induced Alkylation of a 2‘-Aminoglucose Rebeccamycin Derivative to Both A·T and G·C Base Pairs in DNA

5. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.;Bailly;Cancer Res,1999

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemistry and biology of specialized metabolites produced by Actinomadura;Natural Product Reports;2024

2. Indolocarbazole alkaloid Loonamycin A inhibits triple-negative breast cancer cell stemness and Notch signalling;Journal of Pharmacy and Pharmacology;2023-03-01

3. 5,8-Dimethyl-9H-carbazole Derivatives Blocking hTopo I Activity and Actin Dynamics;Pharmaceuticals;2023-02-25

4. Gold Binding Peptide Identified from Microfluidic Biopanning: An Experimental and Molecular Dynamics Study;Langmuir;2018-12-28

5. Topoisomerase 1B poisons: Over a half‐century of drug leads, clinical candidates, and serendipitous discoveries;Medicinal Research Reviews;2018-11-19